Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible Strategy

Area of Science:

• Oncology
• Molecular Biology
• Chemical Biology

Background:

• Despite decades of research and significant investment, conventional cancer therapies like chemotherapy and radiation have limitations.
• Current treatments often fail to meet expectations, necessitating novel therapeutic strategies.

Purpose of the Study:

• To propose a new cancer therapy targeting cancer-stromal synapses.
• To explore the potential of disassembling these synapses for tumor collapse and enhanced treatment precision.

Main Methods:

• Focusing on cancer-stromal synapses, including immunological synapses between cancer and immune cells.
• Utilizing targeted crosslinking chemical agents to disassemble synapse protein clusters.
• Developing therapeutics by attaching cleavable, cell-permeable toxic agents to crosslinkers.

Main Results:

• Cancer-stromal synapses involve ligand-receptor clusters and facilitate focused intercellular signaling.
• Disassembly of these synapses presents a potential strategy for tumor collapse.
• Targeted crosslinking agents offer enhanced safety and precision in cancer therapy.

Conclusions:

• Targeting cancer-stromal synapses represents a universal, cost-efficient, and potentially resistance-proof therapeutic approach.
• This strategy leverages the clustered nature of synapse components for precise drug delivery and efficacy.
• The proposed method may overcome the resistance issues commonly observed with conventional chemotherapy and immunotherapy.